Growing Awareness Regarding Infection to Drive Viral Conjunctivitis Market

Worldwide, virus has been a major cause of conjunctivitis – inflammation of the conjunctiva. IT is pertinent to note here that only is this highly contagious, capable of spreading by sneezing and coughing. It is often seen as occurring with other diseases such as respiratory diseases, influenza, measles, and common cold.

Get Sample Copy of this Report @

As high incidence of eye disorders come to fore along with a number of other viral diseases, global viral conjunctivitis market would chart a sturdy growth over the coming few years. This will create profitable avenues for market players. Besides, it is worth noting here that both patients as well as healthcare providers are now aware of drug and therapy options available for treating viral conjunctivitis, helping the market grow further. It is significant to mention the role of governments across the globe in creating awareness around conjunctivitis. Lebanese government is at the forefront of such initiatives. It collaborated with the education ministry and came up with campaigns around the same.

It is pertinent to note here that the vendor landscape of global viral conjunctivitis market is fragmented and competitive. Both large and small players operate in the market playfield. And, therefore, for players to stay ahead of competitors, a variety of strategies are often needed to be deployed.

A significant strategy is that of entering into alliances with players with whom there are mutual synergies identified. Therefore, collaborations, partnerships, acquisitions, and mergers are noted in the market landscape. In the year of 2017, AdenoPlus and InflammaDry products were acquired by Quidel Corporation. The products mentioned here are from RPS Diagnosis. Key players in the market include Novartis, Pfizer Inc., Merck & Co., and Allergan Inc., among others.

Check Table of Contents of this Report @

It is worth noting here that North America and Europe will account for a sizeable share of the market owing to a mature healthcare infrastructure, high disposable income, and robust reimbursement framework.

Viral Conjunctivitis Market Expands as Incidence of Eye Infections Increases

San Francisco, California, November 29th, 2018: The demand within the global market for viral conjunctivitis has been rising on account of the rising incidence of eye infections across the world. Conjunctivitis is a communicable eye infection characterised by unusual swelling and reddening of the eyes, and in severe cases, the infections could be unbearably painful. The demand within the global market for viral conjunctivitis is expected to escalate as people become aware of the various treatments available for conjunctivitis and the medical industry makes swift recourses. A report added by TMR Research on the global market for viral conjunctivitis is a reflection of the key dynamics that are prognosticated to propel market demand. The title of the report is “Viral Conjunctivitis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025”.

Get Sample Copy of this Report @

The demand within the global market for viral conjunctivitis is projected to increase on account of advancements in the field of ophthalmology. The pain and suffering that the patients have to bear as a result of conjunctivitis has compelled medical professional to prescribe active drugs for swift recovery from the infection. This factor shall play a pivotal role in the growth of the global market for viral conjunctivitis in the years to come.

Based on regions, the demand within the market for viral conjunctivitis in Asia Pacific has been rising on account of the heavy incidence of eye infections in India.

Some of the key players in the global market for viral conjunctivitis are Novartis, Merck & Co., Pfizer Inc., and Allergan Inc.

Read Comprehensive Overview of Report @

Viral Conjunctivitis Market Aided by Favorable Government Policies

San Francisco, California, August 01, 2017: Considering how common viral conjunctivitis is, the demand for medications to speed up its recovery is high. The incidence of viral conjunctivitis is less likely to subside in the coming years, following which, experts forecast steady growth for the global viral conjunctivitis market. In a report, titled “Viral Conjunctivitis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” TMR Research provides a comprehensive overview of the market, underlining the various factors influencing its trajectory this far.

The report compiles exhaustive information sourced via proven research methodologies. To provide a holistic overview, information provided in the report is substantiated using relevant graph, statistics, and infographs. Furthermore, expert opinions form a very important part of the report. Information thus provided is intended to help stakeholders have a more comprehensive overview of the global viral conjunctivitis market.

TMR Research forecasts the global viral conjunctivitis market to progress at a full tilt, deriving growth primarily from the high incidence of eye disorders. Viral conjunctivitis constitute a major portion of the acute conjunctivitis witnessed worldwide, finds TMR Research. The growing awareness regarding the same will positively influence the market. Besides this research and development of novel medications to prevent and treat viral conjunctivitis will give significant impetus to the market in the coming years. Government initiatives in this regard have been commendable. Especially across developing and underdeveloped nations, governments have focused their efforts toward educating people about viral conjunctivitis, its symptoms, and common treatment methods.

For instance, the Public Health Ministry of Lebanon has commenced a campaign for spreading awareness about the diseases in association with the Ministry of Education and Higher Learning. Such initiatives will emerge as chief market drivers in the coming years. According to statistics revealed by the US government authority, nearly 5 million cases of viral conjunctivitis are reported every year. Furthermore, about US$589 million is spent every year in the treatment of viral conjunctivitis. While the statistics indicate high incidence of the disease, a factor that will aid the market’s expansion, lack of awareness could hinder the market’s growth across remote locations.

Pfizer Inc., Allergan Inc., Merck & Co., and Novartis are some of the most prominent vendors operating in the global viral conjunctivitis market. Besides this, the market exhibits the presence of a large number of companies, which is indicative of its fragmented vendor landscape. To gain a stronghold a majority of players are keen on mergers, acquisitions, and strategic collaborations. The report profiles the leading companies operating in the global viral conjunctivitis market, discussing in detail their product portfolio, financial overview, strategic collaborations, and marketing strategies. The report is therefore intended to enable companies take informed decision to capitalize on the prevailing market trends.

Click on the link below to request a sample copy of the report